Anbio Biotechnology Class A Ordinary Shares

NNNNNASDAQHealthcare● Active

$17.22

$-5.77(-25.10%)

Market Cap$755806464

P/E Ratio—

52W High$55.65

52W Low$8.3

Avg Volume28K

Open$22.68

Beta4.34

Overview

Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NNNN · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: Apr 7, 2026

EPS Actual

$0.07

Revenue

$0.00B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

Apr 7, 2026

After Market Close

NNNN reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Next earnings date not yet announced.

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	Apr 7, 2026	—	$0.07	—	$0.00B	—	—

Q2 FY2026

Apr 7, 2026

EPS Actual

$0.07

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for NNNN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	Apr 7, 2026	—	$26.15	$27.37	+4.67%

Q2 FY2026+4.67%

Report Date

Apr 7, 2026

EPS Beat/Miss

—

Price Before

$26.15

Price After

$27.37

Beat Rate0 / 1 quarters

Largest Move+4.67% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Anbio Biotechnology Class A Ordinary Shares (NNNN) most recently reported earnings on April 7, 2026 for Q2 FY2026, posting EPS of $0.07 (in line with the analyst consensus of —).

Each quarter, investors track NNNN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NNNN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NNNN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NNNN earnings · 4 questions

Anbio Biotechnology Class A Ordinary Shares's next earnings report is expected around TBD. NNNN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NNNN historically reports after market close (AMC).

NNNN earnings datewhen is NNNN earningsNNNN next earnings datewhen does NNNN report earningsNNNN earnings calendar

▸ Source: FMP · Anbio Biotechnology Class A Ordinary Shares SEC filings · US GAAP · Anbio Biotechnology Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026